We then examined the relationship between gene amplification and genome doubling in breast cancer, by comparing CCNE1, CCNE2, CCND1 and CCND2 gene amplification in non-genome doubled and genome doubled tumours. This evidence concerns the gene CCNE2 and breast cancer.